- Home
- NARI vs CAAP Comparison
NARI vs CAAP Comparison
Compare NARI & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NARI
- CAAP
- Stock Information
- Founded
- NARI 2011
- CAAP 1998
- Country
- NARI United States
- CAAP Luxembourg
- Employees
- NARI N/A
- CAAP N/A
- Industry
- NARI Medical/Dental Instruments
- CAAP Aerospace
- Sector
- NARI Health Care
- CAAP Consumer Discretionary
- Exchange
- NARI Nasdaq
- CAAP Nasdaq
- Market Cap
- NARI 3.0B
- CAAP 2.4B
- IPO Year
- NARI 2020
- CAAP 2018
- Fundamental
- Price
- NARI $49.66
- CAAP $18.78
- Analyst Decision
- NARI Buy
- CAAP Strong Buy
- Analyst Count
- NARI 10
- CAAP 1
- Target Price
- NARI $59.13
- CAAP $21.50
- AVG Volume (30 Days)
- NARI 918.3K
- CAAP 179.8K
- Earning Date
- NARI 10-28-2024
- CAAP 11-20-2024
- Dividend Yield
- NARI N/A
- CAAP N/A
- EPS Growth
- NARI N/A
- CAAP 114.63
- EPS
- NARI N/A
- CAAP 2.22
- Revenue
- NARI $574,498,000.00
- CAAP $1,471,077,000.00
- Revenue This Year
- NARI $24.59
- CAAP $27.07
- Revenue Next Year
- NARI $18.28
- CAAP $19.62
- P/E Ratio
- NARI N/A
- CAAP $8.43
- Revenue Growth
- NARI 22.41
- CAAP N/A
- 52 Week Low
- NARI $36.73
- CAAP $12.70
- 52 Week High
- NARI $67.13
- CAAP $19.98
- Technical
- Relative Strength Index (RSI)
- NARI 53.46
- CAAP 50.74
- Support Level
- NARI $47.96
- CAAP $17.67
- Resistance Level
- NARI $52.59
- CAAP $19.98
- Average True Range (ATR)
- NARI 2.13
- CAAP 0.78
- MACD
- NARI -0.36
- CAAP -0.10
- Stochastic Oscillator
- NARI 29.77
- CAAP 47.84
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.